The US Food and Drug Administration has approved vimseltinib (Romvimza, Deciphera Pharmaceuticals, LLC) to treat adult ...
Funding freezes, legal fights, chaos — no one in medical research knows what will come, except that as of January 22, 2025, ...
Robert F. Kennedy, Jr, will lead the nation’s largest health and human services agency after today’s US Senate vote. Many ...
The MHRA has eased sodium valproate restrictions for men, dropping dual specialist reviews for current patients.
Physicians are increasingly enthusiastic about the future of artificial intelligence (AI) in healthcare generally and in ...
The European Medicines Agency has started a review of medicines containing finasteride and dutasteride following concerns ...
Alerts delivered via the electronic health record temporarily reduces unnecessary screening and treatment but does not create ...
A game-changer for obesity and heart failure? Dr Pandey reveals breakthrough GLP-1 trial results that show reduced cardiovascular risk and better outcomes for HFpEF patients. Don’t miss this!
Some results have been hidden because they may be inaccessible to you
Show inaccessible results